首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
In an age where people promiscuously post personal data on the web and regularly click "I agree" to reams of legalese they have
In an age where people promiscuously post personal data on the web and regularly click "I agree" to reams of legalese they have
admin
2014-09-09
94
问题
In an age where people promiscuously post personal data on the web and regularly click "I agree" to reams of legalese they have never read, news of yet another electronic consent form might seem like a big yawn. But for the future of genomics-related research the Portable Legal Consent, to be announced shortly by Sage Bionetworks, a non-profit research organisation based in Seattle, is anything but mundane. Indeed, by reversing the normal way consent to use personal data is acquired from patients in clinical trials, it could spell a new relationship between scientists and the human subjects of their research, with potential benefits that extend well beyond genomics.
The heart of Portable Legal Consent is the notion that anyone who signs up for a clinical trial, or simply has his genome read in order to anticipate the risk of disease, should easily be able to share his genomic and health data not just with that research group or company, but with all scientists who are prepared in turn to accept some sensible rules about how they may use the data. The main one of these is that the results of investigations which include such "open source" data must, themselves, be freely and publicly available. In much the same vein as the open-source-software movement, the purpose of this is to increase the long-term value of the data, by allowing them to be reused in ways that may not even have been conceived of at the time they were collected.
That approach contrasts with today’s system of secretive data silos for particular studies of specific diseases. Patients sometimes discover that they have even signed away their rights to see their own data. That may serve the narrow interests of a research group or drug company intent on keeping competitors at bay. But the potential of genomic data to provide further insights, perhaps in completely novel contexts, is huge. Also, teasing out correlations between particular genotypes and diseases in a statistically meaningful way requires large sets of data; the larger the set, the more believable the correlations. Portable Legal Consent brings the promise of very large data sets indeed.
Even for academia and industry, these benefits should eventually outweigh the short-term drawbacks of sharing. Indeed, according to John Wilbanks, the creator of Portable Legal Consent, representatives of several drug companies have expressed enthusiasm about Sage Bionetworks’ approach. And appealing features, such as so-called syndicating technology, which automatically informs both researchers and volunteers about new data relevant to a specific drug or disease, should reduce the resistance of individual researchers to the loss of control of what they used to think of as their own data. Of course, sharing in this open-ended way carries risks. The data involved are "de-identified"—meaning they cannot immediately be traced to a specific individual. But as Mr Wilbanks notes, this is not a foolproof guarantee of anonymity.
Data shared might, for example, be traced back to their owner by sophisticated search algorithms. Or some malevolent hacker might expose them to the world. Those squeamish about sharing their personal information should probably not sign the consent form, Mr Wilbanks counsels. But those who believe the benefit of doing so—accelerating the pace of medical research— outweighs the risks can start to pool their own data next month on a special website: weconsent. us. To make sure consent is truly informed, Mr Wilbanks and his team have gone to great lengths to explain the consequences to signatories. There is an online tutorial that cannot be bypassed. Uploaded information may be removed from the database on request, at any time, but the provider is clearly warned that it may have already found its way into places from which it cannot be erased.
Sage Bionetworks hopes 25,000 people will sign up in the first year, either because trial organisers choose to adopt the protocol or volunteers insist on it. But to be really useful, the database would need to grow to ten or 100 times this size. Mr Wilbanks has therefore started discussions with several firms that offer commercial genetic tests for a range of diseases. It is also linking up with an organisation that helps almost 150,000 people find those with similar illnesses, in order to share their experiences.
So far, the Portable Legal Consent is valid only in America, although Sage Bionetworks is looking at ways of adapting it to fit the legal frameworks of China and the EU. How quickly the idea will catch on remains to be seen. But if it does, other sorts of researchers who rely on gathering personal data—for example in sociology or in tracking energy use in homes—may find it attractive. And that would enable research of a sort that is now impossible, by opening up the field of quantifiable social science.
What is the Portable Legal Consent? Why does the author say that the Consent is "anything but mundane"(para. 1)?
选项
答案
an "electronic consent form"/announced by Sage Bionetworks/related to the future of genomics-related research/to form a new relationship between scientists and the human subjects of their research/the main point: anyone who signs up for a clinical trial or has his genome read in order to anticipate the risk of disease, should be able to share his genomic + health data with that research group/company + scientists who are prepared in turn to accept some sensible rules about how they may use the data/potential benefits extends "well beyond genomics"
解析
转载请注明原文地址:https://kaotiyun.com/show/9XSO777K
本试题收录于:
NAETI高级口译笔试题库外语翻译证书(NAETI)分类
0
NAETI高级口译笔试
外语翻译证书(NAETI)
相关试题推荐
MostpeoplewouldbeimpressedbythehighqualityofmedicineavailabletomostAmericans.Thereisalotofspecialization,a
MostpeoplewouldbeimpressedbythehighqualityofmedicineavailabletomostAmericans.Thereisalotofspecialization,a
WewishtoexpressoursatisfactionatthistotheSpecialCommittee,theiractivitiesdeserveencouraged.
Modernindustrialsocietygrantslittlestatustooldpeople.Infact,suchasocietyhasasystemofbuilt-inobsolescence.The
Modernindustrialsocietygrantslittlestatustooldpeople.Infact,suchasocietyhasasystemofbuilt-inobsolescence.The
Modernindustrialsocietygrantslittlestatustooldpeople.Infact,suchasocietyhasasystemofbuilt-inobsolescence.The
Modernindustrialsocietygrantslittlestatustooldpeople.Infact,suchasocietyhasasystemofbuilt-inobsolescence.The
Throughreceivingfinancialsupportfromfamily,communityorthegovernment,isallowed,itisneveradmired.
Fornearlyacentury,twoUnitedStatesgovernmentalagencies,theUnitedStatesArmyCorpsofEngineersandtheBureauofRecla
随机试题
简述财政支出效益的特点。
Faces,likefingerprintsareunique.Didyou【36】wonderhowitispossibleforusto【37】people?Evenaskilledwriterprobablyco
【B1】【B9】
肺癌肺外综合征最常见的是
以上哪项是乙胺丁醇的毒性不良反应以上哪项是异烟肼的毒性不良反应
位于长江下游的古典私家园林是()。
下列属于法律制裁的是()。
曲面片z2=X2+y2(0≤z≤1)的形心坐标为________。
Whentravelerslackanawarenessof【51】timeisregulatedinaforeigncountry,theycanexpecttofeelsomewhatdisoriented.S
黄河是亚洲第三、世界第六长的河流。“黄”这个字描述的是其河水浑浊的颜色。黄河发源于青海,流经九个省份,最后注入渤海。黄河是中国赖以生存的几条河流之一。黄河流域(riverbasin)是中国古代文明的诞生地,也是中国早期历史上最繁荣的地区。然而,由于极具破
最新回复
(
0
)